Cargando…
GDNF and Parkinson’s Disease: Where Next? A Summary from a Recent Workshop
The concept of repairing the brain with growth factors has been pursued for many years in a variety of neurodegenerative diseases including primarily Parkinson’s disease (PD) using glial cell line-derived neurotrophic factor (GDNF). This neurotrophic factor was discovered in 1993 and shown to have s...
Autores principales: | Barker, Roger A., Björklund, Anders, Gash, Don M., Whone, Alan, Van Laar, Amber, Kordower, Jeffrey H., Bankiewicz, Krystof, Kieburtz, Karl, Saarma, Mart, Booms, Sigrid, Huttunen, Henri J., Kells, Adrian P., Fiandaca, Massimo S., Stoessl, A. Jon, Eidelberg, David, Federoff, Howard, Voutilainen, Merja H., Dexter, David T., Eberling, Jamie, Brundin, Patrik, Isaacs, Lyndsey, Mursaleen, Leah, Bresolin, Eros, Carroll, Camille, Coles, Alasdair, Fiske, Brian, Matthews, Helen, Lungu, Codrin, Wyse, Richard K., Stott, Simon, Lang, Anthony E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458523/ https://www.ncbi.nlm.nih.gov/pubmed/32508331 http://dx.doi.org/10.3233/JPD-202004 |
Ejemplares similares
-
Gene Therapy for the Treatment of Parkinson’s Disease: The Nature of the Biologics Expands the Future Indications
por: Fiandaca, Massimo S., et al.
Publicado: (2012) -
Evaluation of an AAV2-Based Rapamycin-Regulated Glial Cell Line-Derived Neurotrophic Factor (GDNF) Expression Vector System
por: Hadaczek, Piotr, et al.
Publicado: (2011) -
The Use of Convection-Enhanced Delivery with Liposomal Toxins in Neurooncology
por: Fiandaca, Massimo S., et al.
Publicado: (2011) -
PET 6-[(18)F]fluoro-L-m-tyrosine Studies of Dopaminergic Function in Human and Nonhuman Primates
por: Eberling, Jamie L., et al.
Publicado: (2008) -
Intermittent convection-enhanced delivery of GDNF into rhesus monkey putamen: absence of local or cerebellar toxicity
por: Luz, Matthias, et al.
Publicado: (2018)